URB597 Size:2mg solid Ali S et al

Ali S et al

LY2157199 treatment stimulates hematopoiesis from primary MDS bone marrow specimens

is orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway

CAS Number: 90141-22-3

24 and 72 hours) has the growth-inhibitory effect and leads to a dose-dependent decrease in numbers of SKOV-3 and OVCAR-3 cells

URB597 Size:2mg solid Ali S et alURB597, also known as KDS 4103, is a relatively selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH). FAAH is the primary degradatory enzyme for the endocannabinoid anandamide and, as such, inhibition of FAAH leads to an accumulation of anandamide in the CNS and periphery where it activates cannabinoid receptors. In pre clinical laboratory tests researchers found URB597 increased the production of endocannabinoids resulting in